Improving venous symptoms in C0s-C1s patients after multicomponent diosmin-based preparation: Initial experience

Area of Science:

• Vascular Medicine
• Pharmacology
• Medical Research

Background:

• Chronic venous disease (CVD) management is debated regarding drug therapy safety, compliance, and efficacy.
• Diosmin demonstrates benefits in advanced chronic venous insufficiency (CVI) classes (C3-C6).
• Evidence for diosmin's effectiveness in early CVI stages (C0-C1) is limited.

Purpose of the Study:

• To evaluate the positive impact of a novel diosmin-based drug therapy.
• To assess symptom relief in patients with early-stage CVI (C0-C1).
• To address the documented gap in evidence for diosmin use in C0-C1 patients.

Main Methods:

• Analysis of a new diosmin-based drug therapy.
• Focus on a patient population within the C0-C1 CEAP classification.
• Evaluation of venous symptom relief.

Main Results:

• The diosmin-based therapy showed a positive impact on symptom relief.
• Effectiveness in the C0-C1 patient group was observed.
• The study provides data supporting diosmin use in early CVI.

Conclusions:

• Diosmin-based therapy is effective for symptom relief in early-stage CVI (C0-C1).
• This finding contributes valuable evidence for managing milder forms of chronic venous disease.
• Further research may explore long-term outcomes and comparative effectiveness.